Replies to post #485252 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I see, so you don't actually believe that A2-73 stabilise and halt AD.

Very few OLE participants still are classified as having MCI and/or early Alzheimer’s disease so ADL can be an appropriate primary end point.

Probably the only honest post from you in a long time.

Good to see!

[Doc328]

Very few OLE participants still are classified as having MCI and/or early Alzheimer’s disease so ADL can be an appropriate primary end point.

So did most of the patients on A273 progress from MCI to mild AD in just 1 year

or

As I've posted multiple times, most of the patients were already stage 3 or 4 at study entry

Which is it?